Acrivon Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Acrivon Therapeutics Inc
TickerACRV
CIK #0001781174
CUSIP004890109
SectorLife Sciences - Pharmaceutical Preparations
Address480 Arsenal Way, Suite 100, Watertown, MA 02472
Source [EDGAR]
CIK Filing 2011 - 2025
[0001781174] 10-K
[0001781174] 10-Q
[0001781174] 3
[0001781174] 4
[0001781174] 8-K
[0001781174] D
[0001781174] SC 13D
[0001781174] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Marshall Wace North America LP Acrivon Therapeutics Inc [2023-02-14] 5.9
Chione Ltd Acrivon Therapeutics Inc [2022-11-28] 18.5
RA Capital Management LP Acrivon Therapeutics Inc [2022-11-28] 23.07
Sands Capital Life Sciences Pulse Fund II LP Acrivon Therapeutics Inc [2022-11-25] 7.9
Citadel Advisors LLC Acrivon Therapeutics Inc [2022-11-21] 7.8
Perceptive Advisors LLC Acrivon Therapeutics Inc [2022-11-18] 14.4
Form 3/4/5 Filer 2011 - 2025
Gamelin Erick
Acrivon Therapeutics, Inc.
Masson Kristina
Blume-Jensen Peter
Devroe Eric
Peterson Katharine
Miller Mary
Levy Adam D.
Palani Santhosh
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II, L.P.
Shah Rajeev M.
BAUM Charles M
Magovcevic-Liebisch Ivana
DiRocco Derek
Tomsicek Michael John
Shacham Sharon
Perceptive Life Sciences Master Fund Ltd
Perceptive Advisors LLC
Edelman Joseph
Mirza Mansoor Raza
Cuillerot Jean-Marie
Holm-Jorgensen Rasmus
Czernik Marcin
Smolokowski Wiaczeslaw
Hadjimichael Andreas
Nikolaou Anastasis
Chione Ltd
Wellington Biomedical Innovation Master Investors (Cayman) I
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2025-06-30] SOLE 8,340,508 8,340,508
Sands Capital Alternatives, LLC [2025-06-30] SOLE 2,122,605 2,122,605
Citadel Advisors LLC [2025-06-30] DFND 1,895,519 1,895,519
Wellington Management Group LLP [2025-06-30] DFND 0 888,130
Vanguard Group Inc [2025-06-30] SOLE 0 588,794
Renaissance Technologies LLC [2025-06-30] SOLE 509,295 509,295
BlackRock, Inc. [2025-06-30] SOLE 406,201 407,622
Acorn Capital Advisors LLC [2025-06-30] SOLE 405,237 405,237
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 382,234 382,234
Jane Street Group LLC [2025-06-30] DFND 311,829 311,829
Millennium Management LLC [2025-06-30] SOLE 296,239 296,239
Marshall Wace LLP [2025-06-30] OTR 0 181,187
Two Sigma Investments LP [2025-06-30] SOLE 181,172 181,172
Geode Capital Management LLC [2025-06-30] DFND 164,362 164,362
Squarepoint Ops LLC [2025-06-30] DFND 0 152,605
HRT Financial LP [2025-06-30] DFND 145,895 145,895
Goldman Sachs Group Inc [2025-06-30] DFND 140,055 140,055
XTX Topco Ltd [2025-06-30] DFND 106,119 106,119
State Street Corp [2025-06-30] DFND 67,145 67,145
Charles Schwab Investment Management Inc [2025-06-30] SOLE 63,636 63,636
Morgan Stanley [2025-06-30] DFND 62,510 63,016
Northern Trust Corp [2025-06-30] DFND 46,776 46,776
Susquehanna International Group LLP [2025-06-30] OTR 43,860 43,860
Two Sigma Advisers LP [2025-06-30] SOLE 31,200 32,600
Citigroup Inc [2025-06-30] DFND 32,382 32,382
Bridgeway Capital Management LLC [2025-06-30] SOLE 22,900 22,900
Baker Bros Advisors LP [2025-06-30] SOLE 22,809 22,809
Quadrature Capital Ltd [2025-06-30] OTR 0 22,175
AQR Capital Management LLC [2025-06-30] DFND 21,954 21,954
Barclays PLC [2025-06-30] SOLE 20,925 20,925
Prev | Page 7 | Next
Terms | Privacy | Guide
tony@aum13f.com